Concepedia

Ewa Matczak

EM

15

Publications

1.3K

Citations

14

H-Index

1999

Active since

Affiliations

Pfizer (United States)(Current)

Memorial Sloan Kettering Cancer Center

Universitätsklinikum Aachen

University of Milano-Bicocca

Cleveland Clinic

Ewa Matczak is an author at Pfizer (United States) specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1999–2017

15

Publications

15

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

Martin Gore, Cezary Szczylik, Camillo Porta et al. · British Journal of Cancer · 2015 · 190 citations · Full text

Janus kinase 2 is involved in stromal cell–derived factor-1α–induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells

Xuefeng Zhang, Jianfeng Wang, Ewa Matczak et al. · Blood · 2001 · 170 citations · Full text

Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials

Ana M. Molina, Xun Lin, Beata Korytowsky et al. · European Journal of Cancer · 2013 · 157 citations

, , +9

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma

Robert J. Motzer, Bernard Escudier, Ronald M. Bukowski et al. · British Journal of Cancer · 2013 · 135 citations · Full text

Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

Jörge E. Cortes, H. Jean Khoury, Hagop M. Kantarjian et al. · American Journal of Hematology · 2016 · 110 citations · Full text

, , +14

Rows per page

1–5 of 15